Medical News

RSS

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

A new report published in the January issue of the Journal of Vascular Surgery® evaluates the rate of reinterventions and readmissions after initial abdominal aortic aneurysm repair, 30-day mortality and the effect on long-term survival.

30 Dec 2010

Number of shares, votes in Medivir have changed due to employee stock options

The number of shares and the number of votes in Medivir have changed as a result of a directed new issue as well as exercise of employee stock options.

30 Dec 2010

Two out of three children experience cyber-bullying

Two out of three children have experienced bullying via the Internet or mobile phones according to a survey made by Telenor in 2008 in Norway. The survey also shows that parents are uncertain about what to do about this kind of bullying.

30 Dec 2010

Race to have the first baby of the new year

"The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of Loyola University Health System.

30 Dec 2010

Loyola University offers tips to avoid the misery of New Year's hangover

Exercise and B vitamins can help cure a hangover, but coffee won't help. These are among the tips that Loyola University Health System family physician Dr. Aaron Michelfelder offers to avoid the misery of a New Year's hangover.

30 Dec 2010

Tips to avoid allergy and asthma triggers at the gym

A New Year's resolution to get in shape is good news for your health. But if you have allergies or asthma, the hidden triggers at the gym may be bad for your condition.

30 Dec 2010

Akorn-Strides joint venture enters purchase agreement with Pfizer for ANDAs

Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.

30 Dec 2010

Children more likely to suffer from appendicitis in areas with few pediatricians

Children who live in areas with fewer pediatricians are more likely to suffer life-threatening ruptures of the appendix than those in areas with more pediatricians, even when accounting for other factors such as the number of hospitals, imaging technology, insurance coverage and the number of surgeons in an area, according to a study from the Johns Hopkins Children's Center.

30 Dec 2010

General anesthesia's similarities with and differences from sleep and coma

The use of general anesthesia is a routine part of surgical operations at hospitals and medical facilities around the world, but the precise biological mechanisms that underlie anesthetic drugs' effects on the brain and the body are only beginning to be understood. A review article in the December 30 New England Journal of Medicine brings together for the first time information from a range of disciplines, including neuroscience and sleep medicine, to lay the groundwork for more comprehensive investigations of processes underlying general anesthesia.

30 Dec 2010

Low levels of microbe-killing molecules improve survival rate of people with CGD

Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease is greatly improved when even very low levels of microbe-killing molecules are present.

30 Dec 2010

Interaction of light with circadian systems

In a new paper published this week in the Proceedings of the National Academy of Sciences, Aziz Sancar, MD, PhD, the Sarah Graham Kenan Professor of Biochemistry and Biophysics in the UNC School of Medicine, and his colleagues have taken an important step in understanding the underlying molecular signals that influence a broad array of biological processes ranging from the sleep-wake cycle to cancer growth and development.

30 Dec 2010

Researchers study molecular mechanisms in early stages of IPN virus infection

Infectious pancreatic necrosis is a serious disease that leads to enormous losses in the salmon industry each year. The virus that causes the disease, IPN, is very prevalent in farmed salmon and trout in Norway. The virus attacks a wide diversity of hosts and has been found to occur in many different fish species, in addition to shellfish and molluscs.

30 Dec 2010

Indoor plants can contribute to patient well-being

Could a plant "intervention" improve the well-being of patients in a difficult rehab process? Scientists from the Norwegian University of Life Sciences and Sweden's Uppsala University investigated this question in a recent study of 436 coronary and pulmonary patients at a Norwegian rehabilitation center.

30 Dec 2010

Matrixx, H.I.G. announce grant of early termination of waiting period under HSR Act

Matrixx Initiatives, Inc. and H.I.G. Capital, LLC ("H.I.G."), a leading global private investment firm, today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to the previously announced acquisition of all outstanding shares of common stock of the Company by affiliates of H.I.G. Accordingly, the condition with respect to the expiration of the applicable waiting periods under the HSR Act has been satisfied.

30 Dec 2010

Enrollment commences in belinostat-Tarceva combination trial for NSCLC

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC).

30 Dec 2010

Heart researchers find no evidence of toxicity in Longevinex

It was Paracelsus, the Renaissance physician who first said "the dose makes the poison." So, you can drink too much wine, or ingest too much resveratrol, but in an unprecedented study, heart researchers report they couldn't find a toxic dose for Longevinex-, a resveratrol-based dietary supplement.

30 Dec 2010

AngioScore initiates worldwide recall of AngioSculpt PTA Scoring Balloon Catheter

On November 15, 2010 AngioScore Incorporated initiated a worldwide recall of the AngioSculpt® PTA Scoring Balloon Catheter, 0.018" OTW, balloon sizes: 4.0x20mm, 5.0x20mm, and 6.0x20mm. This recall was initiated because of a small number of reports from the field of distal bond failure which has resulted in peeling of the bond and/or detachment of the distal end of the scoring element, wherein the proximal end of the scoring element remains secured to the catheter.

30 Dec 2010

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Omega-3 fatty acids from seafood may reduce inflammation, symptoms of gum disease and risk of abnormal heartbeats early after cardiac surgery. One type of omega-3, DHA (docosahexaenoic acid), may also have lasting benefits in visual function for years in children whose mothers consume sufficient prenatal DHA.

30 Dec 2010

Researchers to identify gene variants that cause ischemic stroke

Researchers from the University of Maryland School of Medicine are coordinating an international team of scientists working to identify genes or gene variants that may make a person more likely to have a particular type of stroke called an ischemic stroke.

30 Dec 2010

Clinical Data closes sale of genetic, pharmacogenomic testing and biomarker development business

Clinical Data, Inc. today announced that the Company has closed the sale of its genetic and pharmacogenomic testing and biomarker development business to Transgenomic, Inc. for $15.5 million. The sale completes Clinical Data's transformation into a pharmaceutical company with a deep product pipeline, including two promising late-stage compounds, the most advanced of which is vilazodone, a new treatment in development for Major Depressive Disorder.

30 Dec 2010

Medical News

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

Number of shares, votes in Medivir have changed due to employee stock options

Two out of three children experience cyber-bullying

Race to have the first baby of the new year

Loyola University offers tips to avoid the misery of New Year's hangover

Tips to avoid allergy and asthma triggers at the gym

Akorn-Strides joint venture enters purchase agreement with Pfizer for ANDAs

Children more likely to suffer from appendicitis in areas with few pediatricians

General anesthesia's similarities with and differences from sleep and coma

Low levels of microbe-killing molecules improve survival rate of people with CGD

Interaction of light with circadian systems

Researchers study molecular mechanisms in early stages of IPN virus infection

Indoor plants can contribute to patient well-being

Matrixx, H.I.G. announce grant of early termination of waiting period under HSR Act

Enrollment commences in belinostat-Tarceva combination trial for NSCLC

Heart researchers find no evidence of toxicity in Longevinex

AngioScore initiates worldwide recall of AngioSculpt PTA Scoring Balloon Catheter

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Researchers to identify gene variants that cause ischemic stroke

Clinical Data closes sale of genetic, pharmacogenomic testing and biomarker development business

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News